These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15563760)

  • 1. The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits.
    Choi JS; Han HK
    J Pharm Pharmacol; 2004 Dec; 56(12):1537-42. PubMed ID: 15563760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
    Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
    Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Piao YJ; Choi JS
    Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
    Kim HJ; Choi JS
    Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of naringin pretreatment on bioavailability of verapamil in rabbits.
    Yeum CH; Choi JS
    Arch Pharm Res; 2006 Jan; 29(1):102-7. PubMed ID: 16491851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pioglitazone on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rats.
    Choi JS; Burm JP
    Arch Pharm Res; 2008 Sep; 31(9):1200-4. PubMed ID: 18806964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
    Choi BC; Choi JS; Han HK
    Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of verapamil on the pharmacokinetics of paclitaxel in rats.
    Choi JS; Li X
    Eur J Pharm Sci; 2005 Jan; 24(1):95-100. PubMed ID: 15626582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.
    Dadashzadeh S; Javadian B; Sadeghian S
    Biopharm Drug Dispos; 2006 Oct; 27(7):329-34. PubMed ID: 16892180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin.
    Choi JS; Jo BW; Kim YC
    Eur J Pharm Biopharm; 2004 Mar; 57(2):313-8. PubMed ID: 15018990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic parameters of verapamil and its active metabolite norverapamil in patients with hepatopathy.
    Vlcek J; Macek K; Hůlek P; Brátová M; Fendrich Z
    Arzneimittelforschung; 1995 Feb; 45(2):146-9. PubMed ID: 7710436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride.
    Choi JS; Burm JP
    Arch Pharm Res; 2005 Apr; 28(4):483-7. PubMed ID: 15918524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.
    Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
    Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.
    Choi JS; Li X
    Int J Pharm; 2005 Jun; 297(1-2):1-8. PubMed ID: 15907592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
    Chung JH; Choi DH; Choi JS
    Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of verapamil on the pharmacokinetics of aliskiren in healthy participants.
    Rebello S; Leon S; Hariry S; Dahlke M; Jarugula V
    J Clin Pharmacol; 2011 Feb; 51(2):218-28. PubMed ID: 20413453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
    Li X; Choi JS
    Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs.
    Cermak R; Wein S; Wolffram S; Langguth P
    Eur J Pharm Sci; 2009 Dec; 38(5):519-24. PubMed ID: 19804821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in rats.
    Choi DH; Li C; Choi JS
    Eur J Drug Metab Pharmacokinet; 2009; 34(3-4):163-8. PubMed ID: 20166433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.